Blog

Energy Future favors Hunt debt repayment plan to exit bankruptcy

Hunt has teamed up with junior creditors of Energy Future Holdings to raise about $12.1 billion to repay the power company’s debt and convert its power distribution business, known as Oncor, into a real estate investment trust, or REIT. Energy Future Holdings filed an amended plan of reorganization on Thursday. In a court document, it said the Hunt-backed plan was considered superior to a competing reorganization plan backed by investment

AbbVie's revenue miss raises concerns over Humira sales

AbbVie reported total Humira sales of $3.54 billion for the quarter ended June 30, a 7.6 percent fall from a year earlier. Humira sales have grown on an average 19.2 percent over the past four quarters up to March, according to Thomson Reuters calculations, helped by approvals to treat more indications and expansion into newer markets. AbbVie blamed a change in shipment timing and a strong dollar for a 14.3

FDA approves Novartis's advanced skin cancer drug

(Reuters) – The U.S. Food and Drug Administration approved Novartis AG’s oral pill to treat the most common form of advanced skin cancer. The drug, Odomzo, will carry a boxed warning to alert the risks that it may cause death or severe birth defects in a developing fetus when administered to a pregnant woman. (http://1.usa.gov/1HOgvov) (Reporting by Anjali Rao Koppala in Bengaluru; Editing by Saumyadeb Chakrabarty)